Form D · Other Technology
Biolumic, Inc.
Palmerston North, Q2 · CIK 0001896684
Offering snapshot reported Aug 13, 2026 · SEC filing
- Reported sold
- $8.35M Offering amount: $22.1M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 28, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 13, 2026 | Initial | $8,349,997 | No comparison | 8 | SEC filing |
| Mar 8, 2022 | Initial | $12,482,280 | No comparison | 25 | SEC filing |
| Dec 3, 2021 | Initial | $1,250,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-594145
Source: Form D, filed Aug 13, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Bedbrook | Director |
| Kirsty Bellringer | Director |
| Mark Brown | Director |
| Mary Dimou | Director |
| David Hollinrake | Director |
| Greg Levow | Executive |
| Eli Nir | Director |
| Adrian Percy | Director |
| Richard Perry | Executive |
| Steven Sibulkin | Director, Executive |
| Dean Tilyard | Director |
| Jason Wargent | Director, Executive |
| Johanna Wolfson | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
21 Dairy Farm Road
Palmerston North, Q2, 4440
Palmerston North, Q2, 4440